{
    "clinical_study": {
        "@rank": "15184", 
        "brief_summary": {
            "textblock": "OBJECTIVES:\n\n      I.  Develop an approach for treating patients with homozygous familial hypercholesterolemia\n      using gene therapy with autologous hepatocytes transduced with a normal low-density\n      lipoprotein receptor gene."
        }, 
        "brief_title": "Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia", 
        "condition": "Familial Hypercholesterolemia", 
        "condition_browse": {
            "mesh_term": [
                "Hypercholesterolemia", 
                "Hyperlipoproteinemia Type II"
            ]
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE: Autologous hepatocytes are obtained from a partial hepatectomy and\n      transduced with a recombinant retroviral vector containing the low-density lipoprotein\n      receptor gene.  The transduced hepatocytes are infused via the inferior mesenteric vein 3\n      days following surgery.\n\n      Traditional therapy is discontinued for 4 weeks prior to protocol therapy and may resume 6\n      weeks after the hepatocyte infusion."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "PROTOCOL ENTRY CRITERIA:\n\n        --Disease Characteristics-- Homozygous familial hypercholesterolemia, i.e.: Low-density\n        lipoprotein (LDL) cholesterol greater than 500 mg/dL Autosomal dominant inheritance\n        Early-onset tendon and tuberous xanthomas LDL receptor negative, i.e.: Receptor binding in\n        cultured fibroblasts no more than 20% of normal OR Genotype with 2 previously described,\n        disease-causing alleles Advanced coronary heart disease with relatively poor prognosis,\n        i.e: Angina pectoris History of myocardial infarction Positive exercise tolerance test\n        Atherosclerotic disease in proximal aorta or coronary arteries by ultrasound or angiogram\n        None of the following: Unstable angina pectoris Left ventricular ejection fraction less\n        than 30% Decompensated congestive heart failure Untreated ventricular tachycardia Moderate\n        to severe aortic stenosis Other dyslipidemia Obstructive hepatobiliary disease\n\n          -  Prior/Concurrent Therapy At least 2 weeks since the following: Drugs affecting\n             cholesterol metabolism Plasma exchange LDL apheresis --Patient Characteristics-- Age:\n             Any age Renal: No azotemia No significant proteinuria Other: No hypothyroidism No\n             diabetes"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": "5", 
        "firstreceived_date": "February 24, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004809", 
            "org_study_id": "199/12011", 
            "secondary_id": "UPHS-28040"
        }, 
        "intervention": {
            "intervention_name": "gene therapy", 
            "intervention_type": "Procedure"
        }, 
        "keyword": [
            "familial hypercholesterolemia", 
            "inborn errors of metabolism", 
            "rare disease"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "overall_official": {
            "affiliation": "University of Pennsylvania", 
            "last_name": "James M. Wilson", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 1", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004809"
        }, 
        "source": "Office of Rare Diseases (ORD)", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Pennsylvania", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Center for Research Resources (NCRR)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "June 1992", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2001"
    }, 
    "geocoordinates": {}
}